Cargando…
Registering New Drugs for Low-Income Countries: The African Challenge
Mary Moran and colleagues discuss the best strategies for African regulators to be supported in their efforts to evaluate and approve drugs for their own populations.
Autores principales: | Moran, Mary, Strub-Wourgaft, Nathalie, Guzman, Javier, Boulet, Pascale, Wu, Lindsey, Pecoul, Bernard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051317/ https://www.ncbi.nlm.nih.gov/pubmed/21408102 http://dx.doi.org/10.1371/journal.pmed.1000411 |
Ejemplares similares
-
Strengthening Medical Product Regulation in Low- and Middle-Income Countries
por: Preston, Charles, et al.
Publicado: (2012) -
Maximizing the Impact of Training Initiatives for Health Professionals in Low-Income Countries: Frameworks, Challenges, and Best Practices
por: Cancedda, Corrado, et al.
Publicado: (2015) -
Governing multisectoral action for health in low- and middle-income countries
por: Rasanathan, Kumanan, et al.
Publicado: (2017) -
PRIME: A Programme to Reduce the Treatment Gap for Mental Disorders in Five Low- and Middle-Income Countries
por: Lund, Crick, et al.
Publicado: (2012) -
Household Air Pollution in Low- and Middle-Income Countries: Health Risks and Research Priorities
por: Martin, William J., et al.
Publicado: (2013)